Paper · 42888198

BUB signaling in cancer and molecular insights into targeted therapies.

Baweja B and 7 others. Commun Biol, 2026.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. BUB signaling in cancer and molecular insights into targeted therapies. Papers, record 42888198. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42888198

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: BUB signaling in cancer and molecular insights into targeted therapies.
Journal: Commun Biol
Year: 2026
Publication types: Journal Article, Review
PubMed: https://pubmed.ncbi.nlm.nih.gov/42888198/
DOI: https://doi.org/10.1038/s42003-026-10976-5
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC13675223/
The journal: https://conductscience.org/library/journal-index/101719179
Revised in PubMed: 2026-11-05

Source PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Baweja B	Bhavika
2	Saini C	Chainsee
3	Vats P	Prerna
4	Soni R	Rashi
5	Jangir K	Kritika
6	Patidar P	Prachi
7	Kumar A	Ashok
8	Nema R	Rajeev

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Neoplasms	Major topic
Signal Transduction	Major topic
Protein Serine-Threonine Kinases	Major topic
Molecular Targeted Therapy	Major topic
Humans
Animals
M Phase Cell Cycle Checkpoints

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References194

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	11,451,998	Microtubule-dependent changes in assembly of microtubule motor proteins and mitotic spindle checkpoint proteins at PtK1 kinetochores.	Mol Biol Cell	2001	https://conductscience.org/library/papers/11451998	PubMed
2	34,503,110	Canonical NF-κB Promotes Lung Epithelial Cell Tumour Growth by Downregulating the Metastasis Suppressor CD82 and Enhancing Epithelial-to-Mesenchymal Cell Transition.	Cancers (Basel)	2021	https://conductscience.org/library/papers/34503110	PubMed
3	29,727,616	The BUB3-BUB1 Complex Promotes Telomere DNA Replication.	Mol Cell	2018	https://conductscience.org/library/papers/29727616	PubMed
4	22,649,765	Evaluation of activity and combination strategies with the microtubule-targeting drug sagopilone in breast cancer cell lines.	Front Oncol	2011	https://conductscience.org/library/papers/22649765	PubMed
5	16,628,000	Chromosomal instability, colorectal cancer and taxane resistance.	Cell Cycle	2006	https://conductscience.org/library/papers/16628000	PubMed
6	23,878,276	Loss of BubR1 acetylation causes defects in spindle assembly checkpoint signaling and promotes tumor formation.	J Cell Biol	2013	https://conductscience.org/library/papers/23878276	PubMed
7	35,563,642	Recent Progress on the Localization of PLK1 to the Kinetochore and Its Role in Mitosis.	Int J Mol Sci	2022	https://conductscience.org/library/papers/35563642	PubMed
8	33,892,776	Physiological relevance of post-translational regulation of the spindle assembly checkpoint protein BubR1.	Cell Biosci	2021	https://conductscience.org/library/papers/33892776	PubMed
9	33,955,658	Loss of BubR1 acetylation provokes replication stress and leads to complex chromosomal rearrangements.	FEBS J	2021	https://conductscience.org/library/papers/33955658	PubMed
10	7,969,164	The Saccharomyces cerevisiae checkpoint gene BUB1 encodes a novel protein kinase.	Mol Cell Biol	1994	https://conductscience.org/library/papers/7969164	PubMed

1 to 10 of 194

See all 194 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42888198

GET https://conductscience.org/api/papers/v1/42888198/references?page=2

API reference For AI assistants